• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

New Digital Health Device Can Wirelessly Record & Transmit Patient Tremors in Real-Time

by Our Thought Leaders 04/25/1045 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Klick Labs Debuts First Device to Record and Transmit Parkinson’s Tremors

Aurora Cancer Care, a not-for-profit health care provider in Wisconsin and northern Illinois is launching a precision medicine program powered by Syapse, a provider of precision oncology solutions. The new oncology precision medicine program will help physicians and researchers provide more care options for patients whose cancer is resistant to conventional treatment options like radiation and chemotherapy.

The new multi-disciplinary Oncology Precision Medicine Clinic will be located inside the Vince Lombardi Cancer Clinic at Aurora St. Luke’s Medical Center and will leverage molecular profiling technology to help patients explore additional treatment options that take into consideration the genetic characteristics of their tumors. The new clinic will include representation from medical oncology, pharmacy, pathology, research and genetic counseling services, and will be the first facility in Wisconsin to feature Syapse’s precision medicine software solution that enables oncologists to treat patients with precision medicine. Syapse brings together previously fragmented clinical, molecular, treatment, and outcomes data to support complex clinical decisions and facilitate new physician workflows.

As part of the partnership, Syapse will work with Aurora’s  EHR system to provide clinicians the ability to access and compare real-world treatment and outcomes data from other leading cancer centers across the nation through the Oncology Precision Network (OPeN), the nation’s largest precision oncology data sharing network of not-for-profit health systems that includes Intermountain Healthcare, Stanford Cancer Institute, and Providence St. Joseph Health, and others.

Through OPeN, cancer experts will be able to share treatment and outcomes data from more than 100,000 patients while preserving individual patient privacy and security.

The molecular genetic makeup of each tumor will be compared with patient outcomes, providing potential insights into how certain treatments may be more effective. Through the network and access to real-world data, clinicians can see the impact of treatment options in a shorter timeframe as compared to more traditional clinical trial outcome studies, which can take years to see the results. This increased access to data and outcomes through OPeN can provide more treatment options for patients, faster.

Additionally, Syapse will serve as a ‘match-maker’ for some patients to gain access to more clinical trials by identifying patients who may be eligible. Aurora St. Luke’s Medical Center will be the first location where the Syapse software will be implemented in the fall of 2017, and all 19 Aurora Cancer Care facilities throughout eastern Wisconsin will have access by early 2018.

“Precision medicine is the future of cancer care and a topic of great discussion on both a regional and national level, including at the Cancer Moonshot Summit in 2016,” said James Weese, M.D., F.A.C.S., vice president of Aurora Cancer Care. “To bring the depth and experience of Syapse and OPeN to nearly 8,000 new cancer patients we treat each year means we’ll be able to offer more treatment options, and also make smarter choices on treatments based on analyzing biological markers in tumors to see what’s worked well with similar tumors from across the country.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

5 Ways New Trump Administration Tariffs Are Impacting U.S. Healthcare Now

5 Ways Trump Administration Tariffs Are Impacting U.S. Healthcare Now

iCAD, GE HealthCare Integrate to Advance Breast Cancer Detection with AI

RadNet to Acquire iCAD for $103M in All-Stock Transaction

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |